{"created":"2023-06-19T07:25:35.001572+00:00","id":13530,"links":{},"metadata":{"_buckets":{"deposit":"2bd215ad-e85f-4030-a2d4-8439334b6e37"},"_deposit":{"created_by":69,"id":"13530","owners":[69],"pid":{"revision_id":0,"type":"depid","value":"13530"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013530","sets":["212:255:327"]},"author_link":["22673","22665","22669","22668","22666","22670","22672","22663","22664","22671","22667"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2017","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"168","bibliographicPageStart":"161","bibliographicVolumeNumber":"814","bibliographic_titles":[{},{"bibliographic_title":"European Journal of Pharmacology","bibliographic_titleLang":"en"}]}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model"},{"subitem_title":"Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model","subitem_title_language":"en"}]},"item_type_id":"3","owner":"69","path":["327"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-03-07"},"publish_date":"2019-03-07","publish_status":"0","recid":"13530","relation_version_is_last":true,"title":["Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model"],"weko_creator_id":"69","weko_shared_id":-1},"updated":"2023-06-19T08:44:12.435188+00:00"}